New shot aims to shield heart attack survivors from repeat crises
NCT ID NCT07142265
Summary
This study is testing if starting a cholesterol-lowering injection called inclisiran soon after a heart attack helps prevent future heart-related events like another heart attack or stroke. It will follow 300 patients in Russia for one year to see if the drug, added to their usual care, safely reduces bad cholesterol and stabilizes artery plaque. The main goal is to see if this early treatment leads to fewer serious heart problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGCheboksary, 428000, Russia
-
Novartis Investigative Site
RECRUITINGKemerovo, 650002, Russia
-
Novartis Investigative Site
RECRUITINGMoscow, 105203, Russia
-
Novartis Investigative Site
RECRUITINGNovosibirsk, 630051, Russia
-
Novartis Investigative Site
RECRUITINGPetrozavodsk, 185019, Russia
-
Novartis Investigative Site
RECRUITINGRostov-on-Don, 344010, Russia
-
Novartis Investigative Site
RECRUITINGUlan-Ude, 670031, Russia
Conditions
Explore the condition pages connected to this study.